Carlo De Matteis,Lucilla Crudele,Ersilia Di Buduo,Silviya Cantatore,Raffaella Maria Gadaleta,Marica Cariello,Patrizia Suppressa,Gianfranco Antonica,Elsa Berardi,Giusi Graziano,Antonio Moschetta
Our data suggest an intriguing scenario whereby HHcy is present in patients with MASLD and is associated to lower vitamin D and altered glucose and lipid profile. Thus, considering Hcy levels may help clinicians with the management of patients with increased MASLD risk.